Moderna, Inc. — Director's Dealing 2020

Jun 4, 2020

SEC Form 4/A — Form 4/A

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-05-01

Reporting Person: Andres Juan (See remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-01	Common Stock	S	3934	$49.69	Disposed	0	Direct

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.36 to $50.28. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.